UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies

BMC genomics, 2011-01, Vol.4 (1), p.13-13, Article 13

2011

Volltextzugriff (PDF)

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up of BRCA1 Mutation Carriers

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8629-8635

2005

Volltextzugriff (PDF)

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma

PloS one, 2009-03, Vol.4 (3), p.e4812-e4812

2009

Volltextzugriff (PDF)

Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists

International journal of cancer, 2008-01, Vol.122 (1), p.177-182

2008

Volltextzugriff (PDF)

Germline p16 mutations in familial melanoma

Nature genetics, 1994-09, Vol.8 (1), p.15-21

1994

Volltextzugriff (PDF)

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2018-01, Vol.6 (1), p.38-69

2018

Volltextzugriff (PDF)

Breast Cancer Risk Polymorphisms and Interaction with Ionizing Radiation among U.S. Radiologic Technologists

Cancer epidemiology, biomarkers & prevention, 2008-08, Vol.17 (8), p.2007-2011

2008

Volltextzugriff (PDF)

Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes

BMC cancer, 2004-03, Vol.4 (1), p.9-9, Article 9

2004

Volltextzugriff (PDF)

Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement

European journal of clinical pharmacology, 2019-08, Vol.75 (8), p.1135-1141

2019

Volltextzugriff (PDF)

Papillary thyroid cancer and polymorphic variants in TSHR-and RET-related genes : a nested case-control study within a cohort of U.S. radiologic technologists

Cancer epidemiology, biomarkers & prevention, 2007, Vol.16 (1), p.174-177

2007

Volltextzugriff (PDF)

The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews

The New England journal of medicine, 1997-05, Vol.336 (20), p.1401-1408

1997

Volltextzugriff (PDF)

Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement

European journal of clinical pharmacology, 2019-09, Vol.75 (9), p.1331-1331

2019

Volltextzugriff (PDF)

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a BRCA1 or BRCA2 Mutation

The New England journal of medicine, 2001-07, Vol.345 (4), p.235-240

2001

Volltextzugriff (PDF)

Polymorphisms in DNA double-strand break repair genes and risk of breast cancer : two population-based studies in USA and Poland, and meta-analyses

Human genetics, 2006-05, Vol.119 (4), p.376-388

2006

Volltextzugriff (PDF)

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

The Lancet (British edition), 1998-10, Vol.352 (9137), p.1337-1339

1998

Volltextzugriff (PDF)

BRCA1/2 testing in hereditary breast and ovarian cancer families: Effectiveness of problem-solving training as a counseling intervention

American journal of medical genetics. Part A, 2004-10, Vol.130A (3), p.221-227

2004

Volltextzugriff (PDF)

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families

Breast cancer research and treatment, 2011-01, Vol.125 (1), p.169-173

2011

Volltextzugriff (PDF)

Segregation Analysis of 231 Ashkenazi Jewish Families for Evidence of Additional Breast Cancer Susceptibility Genes

Cancer epidemiology, biomarkers & prevention, 2003-10, Vol.12 (10), p.1045-1052

2003

Volltextzugriff (PDF)

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

Nature genetics, 1995-10, Vol.11 (2), p.198-200

1995

Volltextzugriff (PDF)

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case–Control Study

JNCI : Journal of the National Cancer Institute, 2003-07, Vol.95 (14), p.1072-1078

2003

Volltextzugriff (PDF)

Genotype–Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations

JNCI : Journal of the National Cancer Institute, 2000-06, Vol.92 (12), p.1006-1010

2000

Volltextzugriff (PDF)

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1

Nature genetics, 1996-10, Vol.14 (2), p.188-190

1996

Volltextzugriff (PDF)

A Single Nucleotide Polymorphism in the 5′ Untranslated Region of RAD51 and Risk of Cancer among BRCA1/2 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2001-09, Vol.10 (9), p.955-960

2001

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(97)

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up of BRCA1 Mutation Carriers

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma

Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists

Germline p16 mutations in familial melanoma

SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States

Breast Cancer Risk Polymorphisms and Interaction with Ionizing Radiation among U.S. Radiologic Technologists

Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes

Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement

Papillary thyroid cancer and polymorphic variants in TSHR-and RET-related genes : a nested case-control study within a cohort of U.S. radiologic technologists

The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews

Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a BRCA1 or BRCA2 Mutation

Polymorphisms in DNA double-strand break repair genes and risk of breast cancer : two population-based studies in USA and Poland, and meta-analyses

FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

BRCA1/2 testing in hereditary breast and ovarian cancer families: Effectiveness of problem-solving training as a counseling intervention

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families

Segregation Analysis of 231 Ashkenazi Jewish Families for Evidence of Additional Breast Cancer Susceptibility Genes

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case–Control Study

Genotype–Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1

A Single Nucleotide Polymorphism in the 5′ Untranslated Region of RAD51 and Risk of Cancer among BRCA1/2 Mutation Carriers

Suchergebnisse filtern